Cargando…
Novel Multiplex MethyLight Protocol for Detection of DNA Methylation in Patient Tissues and Bodily Fluids
Aberrant DNA methylation is a hallmark of cancer and is an important potential biomarker. Particularly, combined analysis of a panel of hypermethylated genes shows the most promising clinical performance. Herein, we developed, optimized and standardized a multiplex MethyLight assay to simultaneously...
Autores principales: | Olkhov-Mitsel, Ekaterina, Zdravic, Darko, Kron, Ken, van der Kwast, Theodorus, Fleshner, Neil, Bapat, Bharati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961737/ https://www.ncbi.nlm.nih.gov/pubmed/24651255 http://dx.doi.org/10.1038/srep04432 |
Ejemplares similares
-
Analysis of repetitive element DNA methylation by MethyLight
por: Weisenberger, Daniel J., et al.
Publicado: (2005) -
DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight
por: Weisenberger, Daniel J., et al.
Publicado: (2008) -
Establishment of the MethyLight Assay for Assessing Aging, Cigarette Smoking, and Alcohol Consumption
por: Endo, Kosuke, et al.
Publicado: (2015) -
Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer
por: White-Al Habeeb, Nicole M. A., et al.
Publicado: (2014) -
Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer()
por: Olkhov-Mitsel, Ekaterina, et al.
Publicado: (2017)